121 related articles for article (PubMed ID: 7588830)
1. Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.
Daschner FD; Grundmann H; Anding K; Lemmen S
Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):536-9. PubMed ID: 7588830
[TBL] [Abstract][Full Text] [Related]
2. Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.
Kropec A; Lemmen SW; Grundmann HJ; Engels I; Daschner FD
Infection; 1995; 23(5):298-300. PubMed ID: 8557389
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils.
Roilides E; Walsh TJ; Pizzo PA; Rubin M
J Infect Dis; 1991 Mar; 163(3):579-83. PubMed ID: 1704903
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor.
Anding K; Kropec A; Schmidt-Eisenlohr E; Benzing A; Geiger K; Daschner F
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):121-4. PubMed ID: 7684679
[TBL] [Abstract][Full Text] [Related]
5. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
[TBL] [Abstract][Full Text] [Related]
6. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro.
Lejeune M; Sariban E; Cantinieaux B; Ferster A; Devalck C; Fondu P
J Infect Dis; 1996 Oct; 174(4):800-5. PubMed ID: 8843219
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro influence of ceftazidime on host defence mechanisms.
Gnarpe H; Belsheim J; Blomqvist C; Lundbäck A; Svensson AC
J Antimicrob Chemother; 1984 Apr; 13(4):369-75. PubMed ID: 6427174
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.
Liles WC; Huang JE; van Burik JA; Bowden RA; Dale DC
J Infect Dis; 1997 Apr; 175(4):1012-5. PubMed ID: 9086172
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung microvessels but are slow to migrate.
van Eeden SF; Lawrence E; Sato Y; Kitagawa Y; Hogg JC
Eur Respir J; 2000 Jun; 15(6):1079-86. PubMed ID: 10885427
[TBL] [Abstract][Full Text] [Related]
10. Effect of priming polymorphonuclear leukocytes with cytokines (granulocyte-macrophage colony-stimulating factor [GM-CSF] and G-CSF) on the host resistance to Streptococcus pneumoniae in chinchillas infected with influenza A virus.
Abramson JS; Hudnor HR
Blood; 1994 Apr; 83(7):1929-34. PubMed ID: 7511443
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
Sultan N; Cirak MY; Erbaş D
Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
[TBL] [Abstract][Full Text] [Related]
14. Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action.
Watanabe Y; Tawara S; Mine Y; Kikuchi H; Goto S; Kuwahara S
J Antibiot (Tokyo); 1986 Feb; 39(2):294-303. PubMed ID: 3514564
[TBL] [Abstract][Full Text] [Related]
15. Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains.
Vranes J
Chemotherapy; 1996; 42(3):177-85. PubMed ID: 8983884
[TBL] [Abstract][Full Text] [Related]
16. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.
Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
J Infect Dis; 1999 May; 179(5):1301-4. PubMed ID: 10191242
[TBL] [Abstract][Full Text] [Related]
17. Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapy.
Cohen DM; Bhalla SC; Anaissie EJ; Hester JP; Savary CA; Rex JH
Clin Lab Haematol; 1997 Mar; 19(1):39-47. PubMed ID: 9146946
[TBL] [Abstract][Full Text] [Related]
18. [Effects of KW-2228 on the function of polymorphonuclear neutrophils in rats for the phagocytosis and killing activity and the production of active oxygen].
Yoshitake H; Sato K
Jpn J Antibiot; 1992 Jan; 45(1):112-20. PubMed ID: 1379650
[TBL] [Abstract][Full Text] [Related]
19. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.
van Spriel AB; van den Herik-Oudijk IE; van Sorge NM; Vilé HA; van Strijp JA; van de Winkel JG
J Infect Dis; 1999 Mar; 179(3):661-9. PubMed ID: 9952373
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
